Nutrien Ltd (NTR) concluded trading on Thursday at a closing price of $54.75, with 4.79 million shares of worth about $262.34 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.82% during that period and on May 08, 2025 the price saw a loss of about -3.30%. Currently the company’s common shares owned by public are about 488.56M shares, out of which, 488.24M shares are available for trading.
Stock saw a price change of -3.51% in past 5 days and over the past one month there was a price change of 16.79%. Year-to-date (YTD), NTR shares are showing a performance of 22.35% which increased to 1.37% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $43.69 but also hit the highest price of $60.87 during that period. The average intraday trading volume for Nutrien Ltd shares is 2.49 million. The stock is currently trading 1.06% above its 20-day simple moving average (SMA20), while that difference is up 5.38% for SMA50 and it goes to 10.99% higher than SMA200.
Nutrien Ltd (NYSE: NTR) currently have 488.56M outstanding shares and institutions hold larger chunk of about 72.41% of that.
The stock has a current market capitalization of $26.75B and its 3Y-monthly beta is at 0.84. PE ratio of stock for trailing 12 months is 51.36, while it has posted earnings per share of $1.07 in the same period. Its PEG reads 8.60 and has Quick Ratio of 0.59 while making debt-to-equity ratio of 0.61. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NTR, volatility over the week remained 2.51% while standing at 2.85% over the month.
Stock’s fiscal year EPS is expected to rise by 11.64% while it is estimated to increase by 4.63% in next year. EPS is likely to grow at an annualized rate of 5.97% for next 5-years, compared to annual growth of -4.35% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on March 13, 2025 offering a Sell rating for the stock and assigned a target price of $53 to it. Coverage by Barclays stated Nutrien Ltd (NTR) stock as an Equal weight in their note to investors on January 21, 2025, suggesting a price target of $56 for the stock. On January 13, 2025, Piper Sandler Upgrade their recommendations, while on January 13, 2025, JP Morgan Upgrade their ratings for the stock with a price target of $50. Stock get an Outperform rating from Raymond James on December 03, 2024.
